.
.
.
Synergen United
Europe
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
Rare Cannabis Genetics. Global Reach. EU Precision.
HOME
Genetics First. Tissue Culture Forward. Europe Ready.
Unlocking Europe’s regenerative cannabis foundation through certified genetics and smart propagation systems.
SynerGen United (i.f.) is the genetic core of Emerald Miles Holding (i.f.).
We preserve, produce, and protect exclusive cannabis cultivars across the World — powered by tissue culture, legal IP infrastructure, and demand-driven partnerships.What sets us apart:
We build an exclusive EU platform for top-tier cuttings, tissue genetics & rare strains.
We are Europe’s first tissue-based genetics company with exclusive access to several of the rarest genetic portfolios on Earth.
🌱 1500+ rare genetics from the Global South (incl. landraces, CBD/CBG/THC strains, terpene-rich varietals)
🔐 Exclusive EU rights renovated Labs (genetic banks)
🔄 Scalable distribution via cutting-edge cultivation systemsWhy Genetics Matter
“Without protected diversity, there is no future for medical or social cannabis.”
We secure plant heritage
We scale clean propagation
We protect access and purpose
ABOUT Us
SynerGen United
We protect, propagate, and deploy rare & stable cannabis genetics — from all continents for Europe.Who We AreSynerGen United EU is building Europe’s premier platform for:• Rare Cannabis Genetics
• Certified GACP Clones & GMP Tissues
• Registration, Licensing & Distribution of elite strainsWe hold exclusive EU rights to 1,500+ rare strains from global Genetic Banks, and are backed by alliances with Universities, Seedbanks and leading European breeders.Our European GACP cutting nursery can deliver 1 million clones in Year 1 –
scaling up to 4 million in Year 2, with full GMP Satellite LAB integration with global Partners.We focus on certified supply chains for medical, recreational, and seed, tissue cultures & clone distribution markets across Europe.📄 Genetics Deck (PDF) - coming soon
EXPANSIONSPLAN
Who We Partner With
- CSCs & Club Consortia (Germany, Spain, Malta)
- EU Medical Growers & Clinics
- Tissue culture labs & agro-innovation networksGlobal and EU-wideActual Milestones (2025):
• Launch of 1st European GACP Cutting Nursery (Austria)
+ Integrate EU GMP Satellite Labs with Partners
+ Expand Certified Distribution & Licensing PlatformNext Milestones (2025–2027):
The planned opening of a 2nd Cutting Nursery Facility in EU to serve the 300% over demand
is now open to onboard the next Investors
Phase | Location | Output | Status | Note |
---|---|---|---|---|
📍 Year 1: Launch Phase | Location: Austria | Output: 1M clones | Status: GACP nursery live (pilot operational secured via LOIs) | Note: First genetics delivered to partner CSCs |
📈 Year 2: Scale-Up | Location: Austria + additional EU sites | Output: 4M clones | Status: Capacity demand secured via LOIs | Note: Includes regional nursery replication & tech transfer |
🌍 Year 3: EU-Wide Distribution | Location: Multi-country rollouts | Output: 12M clones/year | Status: Capacity demand secured via LOIs | Note: Full IP deployment, metadata tracking + licensing platform online |
INVESTORS Briefing
Why Invest in SynerGen United?✅ 1,500+ exclusive genetic strains – unique in the EU
✅ Full compliance: GACP | GMP | IP-ready
✅ 12M+ clones/year demand via signed LOIs (CSCs + medical)
✅ First-mover advantage for licensing & genetics-based IPWe offer:
Equity-based partnerships → share in SynerGen United’s growth
Licensing models → access to genetics & tissue culture tools under IP protection📧 Contact us for more details:
[📄 Investor Charter (PDF)]
[📄 Genetic Value Chain (1-Pager)]
[email protected]
ASSETS
Core Assets• Exclusive Genetic Rights (EU-wide): 1,500+ strains
• EU GACP GMP Production: Scalable up to 12M clones/year
• GMP Tissue Lab: In negotiation with multinational players
• Pre-orders via LOIs: Seedbanks, Clubs, Pharma Distributors
• IP-Based Licensing: Strains & Know-how Packages
• Cutting Tissue Culture Distribution Strategy: EU-in finalisation with legal Partners
PARTNERS
Connected Forces is growing fast — and this list will evolve as our ecosystem does. Stay tuned.
